No, Obamacare (Affordable Care Act) generally does not cover Zepbound (tirzepatide).
Affordable Care Act (ACA) marketplace plans do not typically cover weight-loss medications like Zepbound. This is because the federal government has not mandated that these plans cover such drugs.
Medicaid also generally does not cover Zepbound for weight loss purposes. Medicare is different starting July 1, 2026: through the temporary Medicare GLP-1 Bridge program, eligible people with Medicare drug coverage (Part D) can get certain GLP-1 drugs for weight loss, including the Zepbound KwikPen, for a $50 monthly copayment through December 31, 2027. Single-dose Zepbound pens and vials aren't covered under the program. However, there may be exceptions in certain cases, such as if Zepbound is prescribed for a condition other than weight loss, such as obstructive sleep apnea.
It's important to note that individual insurance plans may have different coverage policies. Some private health insurance plans may choose to cover Zepbound for weight loss. Contact your health insurance provider directly to inquire about their coverage for Zepbound.
Comments
0 comments
Please sign in to leave a comment.